Art

J-GLOBAL ID：201902217111030810   Reference number：19S0416756

Treatment with the SGLT2 inhibitor luseogliflozin improves nonalcoholic steatohepatitis in a rodent model with diabetes mellitus

Author (11)： Qiang, Shirong (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Nakatsu, Yusuke (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Seno, Yasuyuki (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Mori, Keiichi (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Matsunaga, Yasuka (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Yamamotoya, Takeshi (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Kamata, Hideaki (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Asano, Tomoichiro (Department of Medical Chemistry, Division of Molecular Medical Science, Graduate School of Biomedical Sciences, Hiroshima University) ,  Fujishiro, Midori (Department of Internal Medicine, Graduate School of Medicine, University of Tokyo) ,  Sakoda, Hideyuki (Department of Internal Medicine, Graduate School of Medicine, University of Tokyo) ,  Kushiyama, Akifumi (Division of Diabetes and Metabolism, Institute for Adult Disease, Asahi Life Foundation)
Material： Diabetology and Metabolic Syndrome
Volume： 7  Issue： 1  Publication year： 2015 
JST Material Number： SCOPUS  ISSN： 1758-5996 
Country of issue： United Kingdom (GBR)  Language： English (EN)

Terms in the title (1)： SGLT2